WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as $21.4750 and last traded at $21.4750, with a volume of 1900 shares trading hands. The stock had previously closed at $19.78.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, WuXi AppTec currently has a consensus rating of “Moderate Buy”.
View Our Latest Analysis on WUXAY
WuXi AppTec Stock Up 5.8%
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
See Also
- Five stocks we like better than WuXi AppTec
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
